Tag: DCIS

Articles

• Breast cancer types
• Ductal breast cancer and DCIS
• How can young breast cancer survivors avoid a recurrence?
• What happens after treatment for DCIS?
• What should ductal breast cancer patients and survivors eat?

News

• 27% of tumors with LCIS found in core needle biopsy also have invasive breast cancer
• African-American women experience a higher risk of second breast cancer after DCIS
• Alcohol consumption most strongly associated with risk of lobular breast cancer
• Annual MRIs recommended for women at high familial risk of breast cancer
• Breast cancer in old age
• Breast cancer survivors should have careful follow-up regardless of BC type
• Breast reduction surgery may be combined with lumpectomy for DCIS
• Clear surgical margins of at least 1 mm reduce rate of local recurrence
• Coexisting DCIS independently predicts lower tumor aggressiveness in luminal breast cancer
• Cox-2 inhibitor fails to prevent progression from DCIS to breast cancer in mice
• DCIS incidence has increased in recent years
• Factors predicting upstaging from DCIS to invasive breast cancer at time of biopsy
• Long-term outcomes for DCIS patients can vary significantly according to treatment decisions
• Low circulating vitamin D is associated with more aggressive breast cancer
• Measles virus may be associated with breast cancer
• Mouse breast cancer virus appears to be active in some human breast cancer
• MRIs and mammograms both find tumors not found by the other method in women with LCIS
• Multifocal breast cancer has worse prognosis than single tumors
• New method predicts progression of DCIS to invasive breast cancer
• Nipple discharge is a common symptom of early male breast cancer
• Radiation after lumpectomy reduces recurrence for DCIS survivors
• Radiation after surgery for DCIS reduces risk of local recurrence
• Radiation treatment substantially reduces additional breast cancer in women with DCIS
• Residual disease can be prevented for many breast cancer patients with 2 mm clean margins
• Risk of DCIS relapse or progression to invasive cancer continues at least 20 years
• Statin use increases risk of breast cancer for overweight women
• Survival times for metastatic breast cancer have been improving
• Taking aspirin improves breast cancer survival
• Women with DCIS and dense breasts have a higher risk of additional breast cancer

Foods

• holy basil 

Studies

• A comparative analysis of core needle biopsy and final excision for breast cancer: histology and marker expression
• A Quantitative Multigene RT-PCR Assay for Predicting Recurrence Risk after Surgical Excision Alone without Irradiation for Ductal Carcinoma In Situ (DCIS): A Prospective Validation Study of the DCIS Score from ECOG E5194
• A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery
• Accelerated Partial Breast Irradiation Using Once-Daily Fractionation: Analysis of 312 Cases with Four Years Median Follow-Up
• Accuracy and Completeness of Pathology Reporting — Impact on Partial Breast Irradiation Eligibility
• Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor-Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24
• Alcohol Consumption and Risk of Ductal Carcinoma In situ of the Breast in a Cohort of Postmenopausal Women
• Axillary lymph node failure in patients treated with accelerated partial breast irradiation
• Axillary node staging for microinvasive breast cancer: Is it justified?
• Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
• Bisphosphonates may significantly reduce risk of breast cancer
• Breast cancer in the very elderly: Staging, treatment, and outcomes in patients over age 80
• Breast cancer multifocality, disease extent, and survival
• Breast Cancer Reconstruction in the Elderly
• Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
• Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer
• Comparative effectiveness of ductal carcinoma in situ management and the roles of margins and surgeons
• Cyclooxygenase-2 Inhibition for the Prophylaxis and Treatment of Preinvasive Breast Cancer in a Her-2/Neu Mouse Model
• Determination of clear margin in breast-conserving surgery: Is 1 mm needed?
• Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
• Dietary Glycemic Load, Glycemic Index, and Carbohydrate and Risk of Breast Cancer in the Women's Health Initiative
• Disease-free probability after the first primary ductal carcinoma in situ of the breast: a comparison between African-American and White-American women
• Ductal Carcinoma In Situ of the Breast: A Systematic Review of Incidence, Treatment, and Outcomes
• Ductal carcinoma in situ treated with breast-conserving surgery and accelerated partial breast irradiation
• Ductal Carcinoma In Situ With Microinvasion: Prognostic Implications, Long-Term Outcomes, and Role of Axillary Evaluation
• Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
• Enhanced Progesterone Receptor A expression by dietary soy in a hormone-dependent (NMU) model of rat mammary carcinogenesis: implications for tumor progression
• Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision
• Expression of HER2neu in Ductal Carcinoma in situ is Associated with Local Recurrence
• Extra-tumoral breast tissue in breast cancer patients: Variations with steroid contraceptive use
• Factors predicting in-breast tumor recurrence after breast-conserving surgery
• Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
• HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
• Human papilloma virus is associated with breast cancer
• Identification of cell cycle and apoptosis related gene expression by curcumin in an in vitro model for ductal carcinoma in situ
• Improved Outcomes of Breast-Conserving Therapy for Patients with Ductal Carcinoma in Situ
• Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ
• Inhibition of breast cancer progression by a medicinal herb Ocimum sanctum
• Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies
• Is breast-conserving therapy a safe option for patients with tumor multicentricity and multifocality?
• Locoregional recurrence risk after lipofilling in breast cancer patients
• Long-Term Outcome in Patients with Ductal Carcinoma in situ Treated with Breast-Conserving Therapy: Implications for Optimal Follow-up Strategies
• Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
• Mammographic Breast Density and Subsequent Risk of Breast Cancer in Postmenopausal Women According to Tumor Characteristics
• Mammographic Density and Risk of Second Breast Cancer after Ductal Carcinoma In situ
• Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast-A review
• Measles virus antigens in breast cancer
• Mouse Mammary Tumor Virus-like Sequences in Human Breast Cancer
• Network Meta-analysis of Margin Threshold for Women With Ductal Carcinoma In Situ
• New Test Predicts Risk for Recurrence for Patients With DCIS
• Noninvasive Detection of Breast Cancer Lymph Node Metastasis Using Carbonic Anhydrases IX and XII Targeted Imaging Probes
• Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
• Potential Impact of USPSTF Recommendations on Early Diagnosis of Breast Cancer
• Preoperative Breast MRI in the Surgical Treatment of Ductal Carcinoma In Situ
• Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer
• Prospective Multicenter Cohort Study to Refine Management Recommendations for Women at Elevated Familial Risk of Breast Cancer: The EVA Trial
• Residual disease after re-excision lumpectomy for close margins
• Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy/trastuzumab treatment in early breast cancer: Results from the GeparQuattro study (GBG 40)
• Risk Factors for Invasive Breast Cancer When Core Needle Biopsy Shows Ductal Carcinoma In Situ
• Risk for subsequent breast cancer after lobular carcinoma in situ: Do clinical factors matter?
• Risk of needle tract seeding of breast cancer: cytological results derived from core wash material
• Screening Breast MR Imaging in Women with a History of Lobular Carcinoma in Situ
• Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer
• Should palpable DCIS be treated as IDC? A retrospective audit
• Tea consumption and risk of breast cancer
• Ten-Year Risk of Diagnostic Mammograms and Invasive Breast Procedures After Breast-Conserving Surgery for DCIS
• The Association between Prognostic Demographic and Tumor Characteristics of Breast Carcinomas with Serum 25-OH Vitamin D Levels
• The association of metabolic syndrome with triple-negative breast cancer
• The Changing Incidence of In situ and Invasive Ductal and Lobular Breast Carcinomas: United States, 1999-2004
• The influence of margin width and volume of disease near margin on benefit of radiation therapy for women with DCIS treated with breast-conserving therapy
• The Significance of Nipple Discharge of the Male Breast
• The Use of Oncoplastic Reduction Techniques to Reconstruct Partial Mastectomy Defects in Women with Ductal Carcinoma In Situ